Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Continue

Contact information

Email
demin.li@ndcls.ox.ac.uk

Research groups

Banham Group: Haemato-Oncology Group

Demin Li

PhD, MBBS, MSc

Visiting Scientist

Senior Research Fellow

Understanding immune recognition and developing cancer immunotherapy.

Recent publications

Immunopeptidomic Profiling of HLA-A2-Positive Triple Negative Breast Cancer Identifies Potential Immunotherapy Target Antigens.
Journal article

Ternette N. et al, (2018), Proteomics
Development of a T Cell Receptor Mimic Antibody against Wild-Type p53 for Cancer Immunotherapy.
Journal article

Li D. et al, (2017), Cancer Res
The European antibody network's practical guide to finding and validating suitable antibodies for research.
Journal article

Roncador G. et al, (2016), MAbs, 8, 27 - 36
The D0 Ig-like domain plays a central role in the stronger binding of KIR3DL2 to B27 free H chain dimers.
Journal article

Hatano H. et al, (2015), J Immunol, 194, 1591 - 1601
The Leukocyte Immunoglobulin-Like Receptor Family Member LILRB5 Binds to HLA-Class I Heavy Chains.
Journal article

Zhang Z. et al, (2015), PLoS One, 10

More publications

ORCID

0000-0002-7118-3401